Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(510)
•••
Comment by 2b7f6fabon Jul 20, 2017 11:13am
117 Views
Post# 26490516

RE:I posted this in Washngton Post comments section

RE:I posted this in Washngton Post comments section Considering past HC delays it would be a miracle if the GBM trial got underway before the end of this year.
Thor6570 wrote:
Thor6570
6:55 AM EDT
 
 
Canadian company Theralase technologies will be conducting phase 1 trial in US in the next few months. Look at this news release and checkout this company's website. Currently in clinical trial for NMIBC safety of drug TLD1433 proven 99 to 100 % in lab trial for many cancer indications. This drug is activated by lasers and only destroys the cancer cells and leaves healthy cells and tissue intact. They also have proven that there compound creates an immune response in the body to future cancer reoccurrences. The issues are does McCain have the time to wait for the lengthy trial timelines. 
https://www.stockhouse.com/news/press-releases/2016...



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities